Christopher Lipinski, Ph.D.

Adjunct Senior Research Fellow
Pfizer Global Research and Development
Pfizer, Inc., retired

Dr. Lipinski current research interests are: analysis and investigation of drug-like properties; issues related to aqueous and DMSO drug solubility; design and protocol development of combinatorial libraries; issues related to compound storage in DMSO; exact compound batch mode searching and computational ADME prediction. In addition to scientific advisory board positions, he is the author of over 100 papers / presentations and 17 issued U.S. patents. He is the originator of the rule of 5, a widely used filter for drug like properties. He is a member of the editorial board of JPS and a member of: the medicinal chemistry section ACS; PDD section AAPS, EUFEPS and the Society for Biomolecular Screening.

Collette DeChard

Manager Basic Biological Support
Compound Management Group
Merck

Worked at Merck for over 23 years, primarily in the distribution of Natural Products and Chemical Compounds.

Michael J. Sofia, Ph.D.

Group Director
New Leads Chemistry
Bristol-Myers Squibb Company

Dr. Sofia is Group Director of New Leads Chemistry at Bristol-Myers Squibb where he is responsible for Lead Discovery and Program Support Combinatorial Chemistry, External Compound Acquisition, Compound Management, Isolation Chemistry, Biocatalysis and Cheminformatics functions.

Prior to joining BMS Dr. Sofia was Vice President of Chemistry at Intercardia Research Labs (formerly Transcell Technologies) (1993-1999), where he directed research in the areas of infectious diseases drug discovery and combinatorial chemistry technology development. Prior to joining Transcell Technologies, Dr. Sofia was Research Investigator and Project Leader at Lilly Research Labs, Eli Lilly & Co. (1989-1993) in the area of inflammation research. As a Research Investigator at the Squibb Institute for Medical Research, E. R. Squibb (1986-1989), Dr. Sofia focused in the area of atherosclerosis drug discovery.

Dr. Sofia did his postdoctoral training in synthetic organic chemistry as an NIH fellow at Columbia University (1984-1986) after receiving his Ph.D. in organic chemistry from the University of Illinois, Urbana-Champaign (1984). Dr. Sofia received his B.A. degree in chemistry from Cornell University (1980).

Dr. Sofia is on the editorial boards of Solid Phase Organic Synthesis, Current Drug Targets Infectious Disease and Expert Opinion on Therapeutic Targets. He has authored 56 publications and is an inventor on 20 patents.

Timothy Spicer

Research Scientist
Bristol-Myers Squibb Company

Timothy Spicer has been employed at Bristol-Myers Squibb Co. located in Wallingford, Connecticut for more than eight years and is currently a Research Scientist in the Department of Lead Discovery and Profiling. Prior to his current position, he also worked in the Discovery Technologies department as well as Infectious Diseases Department at BMS. Timothy received his educational training at the SUNY Health Science Center at Syracuse, New York. He has authored multiple publications and patents germane to his area of research. Timothy works across multiple organizations and departments as part of a team that implements assays and supports screening on fully automated platforms. He is recognized at BMS and by collaborators as a leader in evaluating new technologies for the purpose of making UHTS the standard.

Send mail to [email protected] with questions or comments about this web site.
Copyright ?1999 Laboratory Robotics Interest Group
LRIG?is a trademark of the Laboratory Robotics Interest Group
Last modified: October 15, 2004

[LRIG Home]